These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15370460)

  • 21. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
    Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
    World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases.
    Ko FJ; Chiang CH; Wu CC; Wu L
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Mar; 6(3):137-43. PubMed ID: 2342156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
    Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
    Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections.
    Lins H; Wallesch CW; Wunderlich MT
    Acta Neurol Scand; 2005 Nov; 112(5):303-8. PubMed ID: 16218912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population.
    Casmiro M; Maitan S; De Pasquale F; Cova V; Scarpa E; Vignatelli L;
    Eur J Neurol; 2005 May; 12(5):369-74. PubMed ID: 15804267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder.
    Nygaard O; Langbakk B; Romner B
    Scand J Clin Lab Invest; 1998 May; 58(3):183-6. PubMed ID: 9670341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome.
    Inoue S; Takahashi H; Kaneko K
    Acta Paediatr Jpn; 1994 Oct; 36(5):485-8. PubMed ID: 7825447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A clinical study on neuron-specific enolase activities in cerebrospinal fluid of neonates].
    Inoue S
    No To Hattatsu; 1992 Nov; 24(6):548-53. PubMed ID: 1419167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid.
    Jacobi C; Reiber H
    Clin Chim Acta; 1988 Sep; 177(1):49-54. PubMed ID: 3052937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological disease.
    Beelen NA; Twijnstra A; van de Pol M; Menheere PP
    Eur J Cancer; 1993; 29A(2):193-5. PubMed ID: 8422282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical demonstration of neuron-specific enolase in neoplasms of the CNS and other tissues.
    Vinores SA; Bonnin JM; Rubinstein LJ; Marangos PJ
    Arch Pathol Lab Med; 1984 Jul; 108(7):536-40. PubMed ID: 6547318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures.
    Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T
    J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cerebrospinal fluid levels of 28 kDa calcium-binding protein in patients with neurological diseases].
    Kiyosawa K; Mokuno K; Takahashi A; Murakami N; Kato K
    Rinsho Shinkeigaku; 1992 Apr; 32(4):388-92. PubMed ID: 1395324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders.
    Lamers KJ; van Engelen BG; Gabreëls FJ; Hommes OR; Borm GF; Wevers RA
    Acta Neurol Scand; 1995 Sep; 92(3):247-51. PubMed ID: 7484080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
    Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.
    Tiseo M; Ardizzoni A; Cafferata MA; Loprevite M; Chiaramondia M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Anticancer Res; 2008; 28(1B):507-13. PubMed ID: 18383893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface markers for diagnosis of central nervous system involvement in lymphoproliferative diseases.
    Ernerudh J; Olsson T; Berlin G; Gustafsson B; Karlsson H
    Ann Neurol; 1986 Nov; 20(5):610-5. PubMed ID: 3539002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.